Stepan (SCL) Tops Q1 EPS by 33c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts SCL Hot Sheet
Price: $68.66 --0%
Financial Fact:
Loss from equity in joint ventures: 0
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Loss from equity in joint ventures: 0
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Stepan (NYSE: SCL) reported Q1 EPS of $0.90, $0.33 better than the analyst estimate of $0.57. Revenue for the quarter came in at $460.5 million versus the consensus estimate of $463.1 million.
For earnings history and earnings-related data on Stepan (SCL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s posts better-than-expected third-quarter comparable sales
- Option Care Health (OPCH) Reports In-Line Q3 EPS
- Harmony Biosciences (HRMY) Misses Q3 EPS by 30c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
